supports Figure 1 by showing further characterization of long and short halflife Wnt reporters in the hypothalamus. It depicts BrdU labeling at two different timepoints, and shows the responsiveness of both reporters to Wnt inhibition. Figure S2 supports Table 1 by showing co-staining of the short half-life Wnt reporter and the dlx5/6:gfp reporter with cell type specific markers. Quantification of these results is provided in Table 1 . 
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Supplemental Experimental Procedures Fish strains
The following lines have been described previously: Tg(TOP:GFP) w25 (Dorsky et al., 2002) , Tg(gfap:GFP) mi2001 (Bernardos and Raymond, 2006) (Ghanem et al., 2003) ,
and Tg(UAS-E1b:NfsB-mCherry) jh17 (Parsons et al., 2009) , Tg(UAS-E1b:Kaede) s1999t (Scott et al., 2007) . lef1 zd11 was made by ZFN mutagenesis (described in detail below).
Tg(hsp701:GFP-axin1)
zd13 was made by inserting a cDNA containing GFP fused to zebrafish axin1 into a pCS2+ backbone vector containing the hsp70-4 promoter. A stable transgenic line was produced by plasmid injection at the 1-cell stage followed by screening for germline transmission of heat shock-induced GFP expression.
Tg(dlx5/6:mCherry) zd14 was made by inserting the 1.4dlx5a/-dlx6a enhancer/promoter (Ghanem et al., 2003) upstream of an mCherry cDNA in a Tol2 destination vector using multisite Gateway cloning (Kwan et al., 2007) . A stable transgenic line was produced by plasmid injection with tol2 mRNA at the 1-cell stage followed by screening for germline transmission of mCherry expression. (TCFSiam:GFP) was made by inserting the 7xTCF-Siam enhancer/promoter (Maretto et al., 2003) upstream of an eGFP cDNA in a Tol2 destination vector using multisite Gateway cloning (Kwan et al., 2007) . A stable transgenic line was produced by plasmid 10 injection with tol2 mRNA at the 1-cell stage followed by screening for germline transmission of GFP. 
Tg
Antibodies
Primary antibodies used were: mouse anti PCNA (Sigma: P8825), rabbit anti Sox3 (Gift from M.
Klymkowsky), rabbit anti GFP (Molecular Probes: A11122), mouse anti GFP (Molecular Probes:
